期刊文献+

结核性胸膜炎患者胸水中MMP-9和TIMP-1水平的临床意义 被引量:3

The Clinical Value of Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase in Diagnosis of Tuberculous Pleural Effusion
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶组织抑制物-1(TIMP-1)及MMP-9/TIMP-1比值在结核性胸膜炎致胸腔积液的形成过程中的作用及鉴别诊断中的价值。方法:采用ELISA法测定36例结核性胸膜炎、30例非结核性胸膜炎患者胸水中的MMP-9和TIMP-1浓度。结果:(1)结核性胸腔积液组胸水中MMP-9浓度、TIMP-1浓度和MMP-9/TIMP-1比值均显著高于非结核性胸腔积液组(83.76±47.36ng.mL-1比38.83±16.53ng.mL-1,600.17±121.46ng.mL-1比481.67±96.36ng.mL-1,0.147±0.097比0.081±0.018,P<0.001)。(2)胸水中MMP-9、TIMP-1、MMP-9/TIMP-1比值在结核性胸腔积液诊断中的敏感性分别为88.9%、72.2%和80.6%,特异性分别为65.4%、63.5%和75.0%。采用胸水MMP-9和TIMP-1串联联合检测的敏感性和特异性分别为33.3%和94.2%,并联联合检测的敏感性和特异性分别为83.3%和53.8%。结论:MMP-9、TIMP-1及MMP-9/TIMP-1比例的失衡与结核性胸膜炎胸腔积液的形成密切相关,它们在结核性胸膜炎所致胸腔积液的诊断中有一定参考价值。 Objective:The aim of this study was to explore the role of matrix metalloproteinase-9 (MMP 9), tissue inhibitor of metalloproteinase-1 (TIMP-1) and the value of MMP-9/TIMP-1 ratio in the pathogenesis and diagnosis of pleural effusion in tuberculous pleuritis. Methods: MMP 9 and TIMP-1 in the pleural fluid were detected by enzyme-linked immunosorbent assay (ELISA) in 66 patients with and without tuberculous pleuritis (of which 36 cases with tuberculous pleuritis). Results: 1. The value of MMP-9,TIMP-1 and the MMP 9/TIMP-1 ratio were higher in tuberculous pleural effusion than in the other group (83.76±47.36 ng· mL^-1 vs. 38.83±16.53 ng· mL^-1, 600.17 ±121. 46 ng· mL^-1 vs. 481.67±96.36 ng· mL^-1,0. 147± 0.097 vs. 0.081 ± 0. 018,P〈0.01 ). 2. In diagnosing tuberculous pleutitis, the sensitivity of MMP-9, MMP -1 and MMP-9/ MMP-1 ratio are respectively 88.9% ,72.2% and 80.6%, the specificity are 65.4% ,63.5% and 75.0% ; however, in the diagnosing process, the sensitivity and specificity are 33. 3% and 94. 2% if we combine MMP-9 and MMP-1 in a series way, 83.3 % and 53.8 % in a parallel way. Conclusion: MMP-9,TIMP-1 and MMP-9/TIMP -1 ratio were closely related to the pleural effusion in tuberculous pleuritis, Patients of pleural effusion which is caused by tuberculous pleurisy exhibit regional MMP -9/ TIMP-1 imbalance of pleural cavity. Detection of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio of pleural effusion contributes to the diagnosis of tuberculous pleural effusion.
出处 《中国临床医学》 2009年第6期835-837,共3页 Chinese Journal of Clinical Medicine
基金 上海市闵行区自然科学基金资助项目(2008MH062)
关键词 结核 胸腔积液 基质金属蛋白酶-9 基质金属蛋白酶组织抑制物-1 Tuberculosis Pleural effusion Matrix metalloproteinase-9 Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献5

  • 1Hurewitz AN, Zucker S, Mancuso P, et al. Human pleural effusions are rich in matrix metalloproteinases[J]. Chest, 1992, 102 (6): 1808- 1814.
  • 2Park K J, Hwang SC, Sheen SS, et al. Expression of matrix met alloproteinase 9 in pleural effusions of tuberculosis and lung cancer[J].Respiration, 2005, 72(2): 166-175.
  • 3Iglesias D, Alegre J, Alemcin C, et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions[J].Eur Respir J, 2005, 25(1); 104- 109.
  • 4肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. 被引量:2870
  • 5Hoheisel G, Sack U, Hui DS, et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuber culous pleuritis[J]. Tuberculosis, 2001, 81(3): 203 -209.

共引文献2869

同被引文献36

  • 1孙瑜,王惠军,李翊卫,王良兴.端粒酶 血管内皮生长因子 粘附分子 基质金属蛋白酶检测对胸腔积液性质鉴别的临床意义[J].中国实用内科杂志:临床前沿版,2006,26(12):1968-1970. 被引量:2
  • 2李雪冰,李宝兰,赖百塘,戈启萍,张新勇.肺结核患者血清MMP-9和VEGF水平检测的临床研究[J].中国防痨杂志,2007,29(2):184-185. 被引量:4
  • 3Hurewitz AN,Zucker S,Mancuso F,et al.Human pleural effusions are rich in matrix raetalloproteinases.Chest,1992,102,1808-1814.
  • 4Park KJ,Hwang SC,Sheen SS,et al.Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.Respiration,2005,72:166-175.
  • 5Iglesias D,Alegre J,Alemán C,et al.Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.Eur Respir J,2005,25:104-109.
  • 6Gross J,Lapiere CM.Collagenolytic activity in amphibian tissues:a tissue culture assay.Proc Natl Acad Sci U S A,1962,48:1014-1022.
  • 7Nelson AR,Fingleton B,Rothenberg ML,et al.Matrix metalloproteinases:biologic activity and clinical implications.J Clin Oncol,2000,18:1135-1149.
  • 8Hoekstra R,Eskens FA,Verweij J.Matrix metalloproteinase inhibitors:current developments and future perspectives.Oncologist,2001,6:415-427.
  • 9Eickelberg O,Sommerfeld CO,Wyser C,et all MMP and TIMP expression pattern in pleural effusions of different origins.Am J Respir Respir Crit Care Med,1997,156:1987-1992.
  • 10Jin HY,Lee KS,Jin SM,et al.Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.Respir Med,2004,98:115-122.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部